Advertisement
UK markets close in 2 hours 44 minutes
  • FTSE 100

    7,842.93
    -34.12 (-0.43%)
     
  • FTSE 250

    19,319.00
    -131.67 (-0.68%)
     
  • AIM

    742.36
    -2.93 (-0.39%)
     
  • GBP/EUR

    1.1669
    -0.0014 (-0.12%)
     
  • GBP/USD

    1.2460
    +0.0021 (+0.17%)
     
  • Bitcoin GBP

    52,415.69
    +2,450.29 (+4.90%)
     
  • CMC Crypto 200

    1,343.86
    +31.23 (+2.44%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.17
    -0.56 (-0.68%)
     
  • GOLD FUTURES

    2,397.70
    -0.30 (-0.01%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,749.14
    -88.26 (-0.49%)
     
  • CAC 40

    8,017.45
    -5.81 (-0.07%)
     

Biogen Asks FDA To Approve Alzheimer's Drug — Why It's Far From A Slam Dunk

Biogen Asks FDA To Approve Alzheimer's Drug — Why It's Far From A Slam Dunk

Biogen stock popped Wednesday after the biotech giant asked the Food and Drug Administration to approve its controversial Alzheimer's treatment, aducanumab.